Xiamen
688278.SSXiamen Amoytop Biotech Co., Ltd. Price (688278.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
405,437,526
(0.3349)%Cash Flow Statement
Xiamen Amoytop Biotech Co., Ltd.Currency: CNY
| YEAR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||
| Net Income | 29.31M
+0% |
5.17M
-82% |
16.00M
+210% |
64.29M
+302% |
116.57M
+81% |
181.20M
+55% |
287.02M
+58% |
555.45M
+94% |
|||||||||||
| Depreciation And Amortiz... | 17.23M | 25.74M | 37.54M | 37.78M | 38.17M | 43.15M | 48.07M | 68.22M | |||||||||||
| Deferred Income Tax | -5,011,200.00 | -1,196,200.00 | -16,308,441.00 | 2.25M | 87.15k | -7,521,720.00 | -2,608,015.00 | 0.00 | |||||||||||
| Stock-Based Compensat... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Change In Working Capital | |||||||||||||||||||
| Accounts Receivables | -37,088,300.00 | -36,093,500.00 | -1,137,923.00 | 9.06M | -42,419,378.00 | -24,537,869.00 | -15,513,141.00 | -205,755,739.00 | |||||||||||
| Accounts Payables | 28.70M | -1,824,900.00 | 64.62M | 19.25M | 9.69M | 63.92M | 61.89M | 153.19M | |||||||||||
| Inventory | -67,371.16 | -10,379,104.64 | -13,860,788.28 | -15,315,567.53 | -29,023,589.52 | -16,871,025.69 | -13,237,252.47 | -57,289,933.36 | |||||||||||
| Other Working Capital | -13,401,454.36 | -39,114,602.20 | 47.17M | 2.25M | 87.15k | -7,521,719.31 | -2,608,015.53 | -11,223,978.11 | |||||||||||
| Other Non-Cash Items | 9.35M | 7.18M | 2.29M | 5.98M | -461,913.67 | -4,561,600.00 | -2,462,830.00 | 9.51M | |||||||||||
| Net Cash Provided By Op... | 42.43M
+0% |
-11,405,318.31
-127% |
89.15M
-882% |
123.30M
+38% |
92.61M
-25% |
234.78M
+154% |
363.16M
+55% |
512.10M
+41% |
|||||||||||
| Investing Activities | |||||||||||||||||||
| Investments In Propert... | -87,032,059.51 | -26,891,362.61 | -14,600,457.09 | -44,826,019.60 | -118,810,216.92 | -190,926,436.04 | -219,168,405.72 | -288,461,196.00 | |||||||||||
| Acquisitions Net | 91.15k | 0.00 | 55.01k | 95.00k | 118.87M | 339.78k | 107.21k | 0.00 | |||||||||||
| Purchases Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | -1,148,100,000.00 | -754,574,122.51 | -700,000,000.00 | -616,000,000.00 | |||||||||||
| Sales Maturities Of Inve... | 3.79k | 0.00 | 0.00 | 0.00 | 884.86M | 833.32M | 629.66M | 598.65M | |||||||||||
| Other Investing Activities | 1.09M | -26,891,362.61 | 55.01k | -44,826,019.60 | -118,810,216.25 | 1.50 | 0.98 | 44.11k | |||||||||||
| Net Cash Used For Inv... | -85,937,120.62
+0% |
-26,891,362.61
-69% |
-14,545,451.53
-46% |
-44,731,019.60
+208% |
-381,992,650.17
+754% |
-111,842,850.05
-71% |
-289,399,000.74
+159% |
-305,764,585.00
+6% |
|||||||||||
| Financing Activities | |||||||||||||||||||
| Debt Repayment | 0.00 | -5,000,000.00 | -10,000,000.00 | -10,000,000.00 | 0.00 | -8,917,582.00 | -10,000,000.00 | 0.00 | |||||||||||
| Common Stock Issued | 0.00 | 0.00 | 0.00 | 0.00 | -13,240,600.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Common Stock Repurch... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Dividends Paid | -4,542,754.12 | -4,023,306.24 | -3,759,064.56 | -3,390,583.31 | -10,170,000.00 | -20,340,000.00 | -40,680,000.00 | -86,648,400.00 | |||||||||||
| Other Financing Activities | 130.96M | -3,270,116.40 | 0.00 | -4,474,000.00 | 293.84M | -4,608,989.00 | -7,688,075.86 | -6,261,578.76 | |||||||||||
| Net Cash Used/Provide... | 126.42M
+0% |
-12,293,422.40
-110% |
-13,759,064.56
+12% |
-17,864,583.31
+30% |
281.11M
-1,674% |
-34,201,572.56
-112% |
-58,368,075.86
+71% |
-92,909,978.76
+59% |
|||||||||||
| Effect Of Forex Changes... | 168.21k | -249,778.84 | 397.99k | 116.68k | -956,286.53 | -485,695.25 | 27.60k | -1,106,326.00 | |||||||||||
| Net Change In Cash | 83.08M | -50,839,882.00 | 61.24M | 60.82M | -9,226,926.00 | 88.25M | 15.42M | 112.32M | |||||||||||
| Cash At Beginning Of Per... | 51.59M | 134.66M | 83.82M | 145.06M | 205.89M | 196.66M | 284.91M | 300.33M | |||||||||||
| Cash At End Of Period | 134.66M | 83.82M | 145.06M | 205.89M | 196.66M | 284.91M | 300.33M | 412.65M | |||||||||||
| Additional Metrics: | |||||||||||||||||||
| Operating Cash Flow | 42.43M | -11,405,318.31 | 89.15M | 123.30M | 92.61M | 234.78M | 363.16M | 512.10M | |||||||||||
| Capital Expenditure | -87,032,059.51 | -26,891,362.61 | -14,600,457.09 | -44,826,019.60 | -118,810,216.92 | -190,926,436.04 | -219,168,405.72 | -288,461,196.71 | |||||||||||
| Free Cash Flow | -44,604,896.51
+0% |
-38,296,680.92
-14% |
74.55M
-295% |
78.48M
+5% |
-26,201,966.92
-133% |
43.85M
-267% |
143.99M
+228% |
223.64M
+55% |
|||||||||||